We are live on ! Find out more
PCRX icon

Pacira BioSciences
PCRX

205 hedge funds and large institutions have $3.58B invested in Pacira BioSciences in 2015 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 75 increasing their positions, 71 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 36

3% more funds holding

Funds holding: 200 → 205 (+5)

6% more repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 71

3% more capital invested

Capital invested by funds: $3.48B → $3.58B (+$102M)

0% more call options, than puts

Call options by funds: $27.4M | Put options by funds: $27.4M

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

Holders
205
Holders Change
+5
Holders Change %
+2.5%
% of All Funds
5.46%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
41
Increased
75
Reduced
71
Closed
36
Calls
$27.4M
Puts
$27.4M
Net Calls
+$19K
Net Calls Change
-$7.62M

Top Buyers

Rank Fund Capital Flow
1
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$73.9M
2
JHIU
Janus Henderson Investors US
Colorado
+$57.4M
3
MCM
Marsico Capital Management
Colorado
+$27.4M
4
SI
Standard Investments
New York
+$27.1M
5
PC
PointState Capital
New York
+$23.3M

Top Sellers

Rank Fund Capital Flow
1
NCGI
Next Century Growth Investors
Minnesota
-$30.8M
2
Bank of New York Mellon
Bank of New York Mellon
New York
-$21.8M
3
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$18.5M
4
CCI
Columbus Circle Investors
-$16.7M
5
GGHC
Gilder Gagnon Howe & Co
New York
-$14.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
HCM
26
Hodges Capital Management
Texas
$26.2M +$105K +1,034 +0.4%
SI
27
Standard Investments
New York
$25.1M +$27.1M +267,032 +1,751%
BIA
28
Biondo Investment Advisors
Pennsylvania
$24.8M -$307K -3,025 -1%
MAA
29
Managed Account Advisors
New Jersey
$23.3M +$7.59M +74,773 +40%
AllianceBernstein
30
AllianceBernstein
Tennessee
$23.1M -$14.9M -146,949 -36%
NCGI
31
Next Century Growth Investors
Minnesota
$22.8M -$30.8M -303,956 -54%
AA
32
Antipodean Advisors
New York
$22M -$8.32M -82,000 -25%
PC
33
PointState Capital
New York
$20.4M +$23.3M +230,000 New
Geode Capital Management
34
Geode Capital Management
Massachusetts
$20.3M +$1.3M +12,796 +6%
Neuberger Berman Group
35
Neuberger Berman Group
New York
$20.2M +$2.64M +25,994 +13%
KCM
36
Key Colony Management
Arkansas
$19.3M +$971K +9,572 +5%
Allianz Asset Management
37
Allianz Asset Management
Germany
$19.1M -$5.53M -54,479 -20%
VOYA Investment Management
38
VOYA Investment Management
Georgia
$17.3M -$9.54M -94,009 -33%
B
39
Baird
Wisconsin
$16.7M +$19M +187,689 New
TCIM
40
TIAA CREF Investment Management
New York
$16M +$5.32M +52,479 +41%
O
41
OrbiMed
New York
$15.6M – – –
PI
42
Putnam Investments
Massachusetts
$15.5M +$17.7M +174,170 New
Asset Management One
43
Asset Management One
Japan
$13.5M +$4.25M +41,878 +39%
Norges Bank
44
Norges Bank
Norway
$13.5M -$1.77M -17,427 -10%
Bank of Montreal
45
Bank of Montreal
Ontario, Canada
$13.4M -$3.94M -38,867 -20%
N
46
Nuveen
North Carolina
$12.8M -$3.42M -33,743 -19%
MTIP
47
Magee Thomson Investment Partners
California
$10.6M -$587K -5,784 -5%
O
48
OppenheimerFunds
New York
$10.4M -$12.7M -125,600 -52%
Charles Schwab
49
Charles Schwab
California
$10.2M +$687K +6,776 +6%
AIMCA
50
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$9.31M +$10.6M +104,835 New
1
2
3 4 5

PCRX Hedge Fund Activity: Q1 2015 in Review

205 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Pacira BioSciences (PCRX) for Q1 2015, worth a combined $3.58B — up 2.9% from $3.48B a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new PCRX positions and 36 closed out — a net gain of 5 holders — while 75 added to existing stakes and 71 trimmed.

The largest buyer was Westfield Capital Management, opening a new position worth an estimated $73.9M. The largest seller was Next Century Growth Investors, cutting an estimated $30.8M.

  • 205 institutional investors held Pacira BioSciences (PCRX) as of Q1 2015, up from 200 in Q4 2014.
  • Funds reported $3.58B of Pacira BioSciences stock for Q1 2015, up 2.9% quarter-over-quarter.
  • 41 funds opened new Pacira BioSciences positions in Q1 2015 and 36 closed out, a net change of +5 holders.
  • The largest Pacira BioSciences buyer in Q1 2015 was Westfield Capital Management, an estimated $73.9M added.
  • The largest Pacira BioSciences seller in Q1 2015 was Next Century Growth Investors, an estimated $30.8M sold.

Based on aggregated 13F filings for Q1 2015.